<DOC>
	<DOCNO>NCT00084539</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Hypofractionated ( few treatment standard radiation therapy ) intensity-modulated radiation therapy ( radiation direct tumor precisely standard radiation therapy ) incorporate boost ( increase amount radiation give treatment ) may kill tumor cell . PURPOSE : This phase II trial study well adjuvant hypofractionated intensity-modulated radiation therapy incorporate boost work treat patient early-stage breast cancer .</brief_summary>
	<brief_title>Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost Treating Patients With Early-Stage Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine toxicity associate adjuvant hypofractionated intensity-modulated radiotherapy use incorporated boost patient early-stage breast cancer . Secondary - Determine long-term cosmetic result quality life patient treat regimen . - Determine long-term local control patient treat regimen . OUTLINE : Patients undergo adjuvant hypofractionated intensity-modulated radiotherapy incorporate boost daily 5 day week 4 week . Quality life assess within 1 month start radiotherapy , 6 week completion radiotherapy , every 6 month 5 year . Patients follow 6 week every six month 5 year . PROJECTED ACCRUAL : A total 37-74 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm carcinoma breast Invasive insitu disease Stage Tis , T1 , T2 ( AJCC stage 0 , I , II ) disease Treated breastconserving surgery within past 8 week Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age 18 Sex Not specify Menopausal status Not specify Performance status ECOG 02 Life expectancy Not specify Hematopoietic Absolute neutrophil count ≥ 1,500/mm^3 Platelet count ≥ 75,000/mm^3 Hepatic Not specify Renal Not specify Other No malignancy within past 2 year except inactive , noninvasive carcinoma cervix nonmelanoma skin cancer No active systemic lupus No history scleroderma No medical psychiatric condition would preclude study participation Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No 6 week since prior adjuvant systemic chemotherapy No concurrent chemotherapy Endocrine therapy Not specify Radiotherapy No prior radiotherapy breast Surgery See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>breast cancer situ</keyword>
</DOC>